Before reading on, I encourage you to check out my Investment Case on Amyris, which puts this blog post into context. The essence of it is this: Synthetic biology operates at the convergence of several disruptive innovation platforms and will be a revolutionizing manufacturing technology in the coming decades. Amyris is the leader in this nascent indust…